Dongping Mo

663 total citations
18 papers, 487 citations indexed

About

Dongping Mo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dongping Mo has authored 18 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Dongping Mo's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (6 papers). Dongping Mo is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (6 papers). Dongping Mo collaborates with scholars based in China and United States. Dongping Mo's co-authors include Feng Yan, Li Tang, Jian Xu, Pan Jiang, Da Wei, Yining Yang, Xiaoming Wang, Shiyang Pan, Ruihong Sun and Xun Tang and has published in prestigious journals such as PLoS ONE, Cancer Letters and Clinica Chimica Acta.

In The Last Decade

Dongping Mo

17 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongping Mo China 12 393 313 83 39 37 18 487
Meina Yan China 12 256 0.7× 154 0.5× 49 0.6× 55 1.4× 29 0.8× 18 365
Chunbo Zhuang China 12 352 0.9× 293 0.9× 38 0.5× 45 1.2× 44 1.2× 19 445
Shilong Fu China 12 207 0.5× 217 0.7× 56 0.7× 56 1.4× 29 0.8× 20 350
Noriko Yamamoto Japan 8 316 0.8× 283 0.9× 46 0.6× 29 0.7× 38 1.0× 18 405
Huiming Dong China 6 270 0.7× 233 0.7× 107 1.3× 37 0.9× 20 0.5× 11 361
Cleidson P. Alves United States 9 282 0.7× 257 0.8× 76 0.9× 21 0.5× 19 0.5× 9 371
Kacper Guglas Poland 15 458 1.2× 445 1.4× 50 0.6× 22 0.6× 33 0.9× 31 563
Jinxiao Liang China 10 218 0.6× 100 0.3× 83 1.0× 39 1.0× 33 0.9× 27 330
Bruna Rodrigues Muys United States 11 455 1.2× 353 1.1× 61 0.7× 29 0.7× 20 0.5× 15 532

Countries citing papers authored by Dongping Mo

Since Specialization
Citations

This map shows the geographic impact of Dongping Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongping Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongping Mo more than expected).

Fields of papers citing papers by Dongping Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongping Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongping Mo. The network helps show where Dongping Mo may publish in the future.

Co-authorship network of co-authors of Dongping Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Dongping Mo. A scholar is included among the top collaborators of Dongping Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongping Mo. Dongping Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Wang, Xiaoming, et al.. (2024). Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer. Clinical & Translational Oncology. 26(8). 1934–1943. 7 indexed citations
3.
4.
Xu, Weiguo, Bin Zhou, Ping Wang, et al.. (2024). N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma. Drug Resistance Updates. 79. 101197–101197. 5 indexed citations
5.
Mo, Dongping, Xun Tang, Dayu Chen, et al.. (2024). tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. Journal of Translational Medicine. 22(1). 4 indexed citations
6.
Tang, Li, et al.. (2023). FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation. Breast Cancer Research and Treatment. 202(2). 397–408. 7 indexed citations
7.
Tang, Li, Da Wei, Xinyu Xu, et al.. (2021). Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1. npj Breast Cancer. 7(1). 94–94. 27 indexed citations
8.
Mo, Dongping, et al.. (2021). tRNA-Derived Fragment tRF-17-79MP9PP Attenuates Cell Invasion and Migration via THBS1/TGF-β1/Smad3 Axis in Breast Cancer. Frontiers in Oncology. 11. 656078–656078. 49 indexed citations
9.
Tang, Li, Yu‐Li Chen, Huanhuan Chen, et al.. (2020). DCST1-AS1 Promotes TGF-β-Induced Epithelial–Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1. Frontiers in Oncology. 10. 280–280. 44 indexed citations
10.
Shi, Jie, et al.. (2020). miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1. Cancer Biology & Therapy. 21(12). 1163–1170. 13 indexed citations
11.
Mo, Dongping, Pan Jiang, Yining Yang, et al.. (2019). A tRNA fragment, 5′-tiRNAVal, suppresses the Wnt/β-catenin signaling pathway by targeting FZD3 in breast cancer. Cancer Letters. 457. 60–73. 125 indexed citations
12.
Wang, Xiaoming, Yining Yang, Da Wei, et al.. (2019). Identification of tRNA-Derived Fragments Expression Profile in Breast Cancer Tissues. Current Genomics. 20(3). 199–213. 31 indexed citations
13.
Xiao, Xuelian, et al.. (2018). miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4. Oncotarget. 9(15). 11977–11988. 25 indexed citations
14.
Mo, Dongping & Fang He. (2018). Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer. Clinical Laboratory. 64(09/2018). 1421–1428. 14 indexed citations
15.
Mo, Dongping, et al.. (2017). MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin. Biotechnology Letters. 39(5). 701–710. 38 indexed citations
16.
Jiang, Li, Dongping Mo, Ruixia Yang, et al.. (2015). Joint effects of serum uric acid and body mass index on risk of prehypertension in Chinese population. Clinica Chimica Acta. 446. 1–5. 6 indexed citations
17.
Mo, Dongping, Bing Gu, Xue Gong, et al.. (2015). miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.. PubMed. 7(9). 1570–9. 36 indexed citations
18.
Wu, Jing, Dongping Mo, Peijun Huang, et al.. (2014). Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6 Promotes Cell Proliferation and Migration by Upregulating DNMT1 via STAT3 Activation. PLoS ONE. 9(3). e93478–e93478. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meina Yan Breakdown of academic impact, for papers by Chunbo Zhuang Breakdown of academic impact, for papers by Shilong Fu Breakdown of academic impact, for papers by Noriko Yamamoto Breakdown of academic impact, for papers by Huiming Dong Breakdown of academic impact, for papers by Cleidson P. Alves Breakdown of academic impact, for papers by Kacper Guglas Breakdown of academic impact, for papers by Jinxiao Liang Breakdown of academic impact, for papers by Bruna Rodrigues Muys
Rankless by CCL
2026